DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Krop I, Abramson V, Colleoni M. et al.
Abstract GS4-07: Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor–positive breast cancer.
Cancer Res 2018;
78: GS4-07-GS04-07
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.